• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用分子动力学模拟洞察 C 位口袋构象变化对 SIRT2 活性的影响。

Insight the C-site pocket conformational changes responsible for sirtuin 2 activity using molecular dynamics simulations.

机构信息

Division of Applied Life Science (BK21 Program), Systems and Synthetic Agrobiotech Center (SSAC), Research Institute of Natural Science (RINS), Gyeongsang National University, Jinju, South Korea.

出版信息

PLoS One. 2013;8(3):e59278. doi: 10.1371/journal.pone.0059278. Epub 2013 Mar 20.

DOI:10.1371/journal.pone.0059278
PMID:23527151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3603925/
Abstract

Sirtuin belongs to a family of typical histone deacetylase which regulates the fundamental cellular biological processes including gene expression, genome stability, mitosis, nutrient metabolism, aging, mitochondrial function, and cell motility. Michael et. al. reported that B-site mutation (Q167A and H187A) decreased the SIRT2 activity but still the structural changes were not reported. Hence, we performed 5 ns molecular dynamics (MD) simulation on SIRT2 Apo-form and complexes with substrate/NAD(+) and inhibitor of wild type (WT), Q167A, and H187A. The results revealed that the assembly and disassembly of C-site induced by presence of substrate/NAD(+) and inhibitor, respectively. This assembly and disassembly was mainly due to the interaction between the substrate/NAD(+) and inhibitor and F96 and the distance between F96 and H187 which are present at the neck of the C-site. MD simulations suggest that the conformational change of L3 plays a major role in assembly and disassembly of C-site. Our current results strongly suggest that the distinct conformational change of L3 as well as the assembly and disassembly of C-site plays an important role in SIRT2 deacetylation function. Our study unveiled the structural changes of SIRT2 in presence of NAD(+) and inhibitor which should be helpful to improve the inhibitory potency of SIRT2.

摘要

Sirtuin 属于典型的组蛋白去乙酰化酶家族,调节包括基因表达、基因组稳定性、有丝分裂、营养代谢、衰老、线粒体功能和细胞迁移在内的基本细胞生物学过程。Michael 等人报道 B 位突变(Q167A 和 H187A)降低了 SIRT2 的活性,但仍未报道结构变化。因此,我们对 SIRT2 apo 形式以及与野生型(WT)、Q167A 和 H187A 的底物/NAD(+)和抑制剂的复合物进行了 5 ns 分子动力学(MD)模拟。结果表明,存在底物/NAD(+)和抑制剂时分别诱导 C 位的组装和拆卸。这种组装和拆卸主要是由于底物/NAD(+)和抑制剂与 F96 和位于 C 位颈部的 F96 和 H187 之间的距离之间的相互作用。MD 模拟表明,L3 的构象变化在 C 位的组装和拆卸中起着主要作用。我们目前的结果强烈表明,L3 的明显构象变化以及 C 位的组装和拆卸在 SIRT2 去乙酰化功能中起着重要作用。我们的研究揭示了 NAD(+)和抑制剂存在下 SIRT2 的结构变化,这应该有助于提高 SIRT2 的抑制效力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ec8/3603925/5a28318f3c1f/pone.0059278.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ec8/3603925/a1be80d85691/pone.0059278.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ec8/3603925/9d0c28437f11/pone.0059278.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ec8/3603925/7d0e2b7cbf75/pone.0059278.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ec8/3603925/76b3bbdee437/pone.0059278.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ec8/3603925/0123ac1075c8/pone.0059278.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ec8/3603925/192790af3574/pone.0059278.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ec8/3603925/c2691fd847ac/pone.0059278.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ec8/3603925/49774781368e/pone.0059278.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ec8/3603925/5ac5e4e73371/pone.0059278.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ec8/3603925/add49fe5465f/pone.0059278.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ec8/3603925/5a28318f3c1f/pone.0059278.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ec8/3603925/a1be80d85691/pone.0059278.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ec8/3603925/9d0c28437f11/pone.0059278.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ec8/3603925/7d0e2b7cbf75/pone.0059278.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ec8/3603925/76b3bbdee437/pone.0059278.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ec8/3603925/0123ac1075c8/pone.0059278.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ec8/3603925/192790af3574/pone.0059278.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ec8/3603925/c2691fd847ac/pone.0059278.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ec8/3603925/49774781368e/pone.0059278.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ec8/3603925/5ac5e4e73371/pone.0059278.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ec8/3603925/add49fe5465f/pone.0059278.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ec8/3603925/5a28318f3c1f/pone.0059278.g011.jpg

相似文献

1
Insight the C-site pocket conformational changes responsible for sirtuin 2 activity using molecular dynamics simulations.利用分子动力学模拟洞察 C 位口袋构象变化对 SIRT2 活性的影响。
PLoS One. 2013;8(3):e59278. doi: 10.1371/journal.pone.0059278. Epub 2013 Mar 20.
2
Molecular modeling study for conformational changes of Sirtuin 2 due to substrate and inhibitor binding.基于配体结合的 Sirtuin 2 构象变化的分子建模研究。
J Biomol Struct Dyn. 2012;30(3):235-54. doi: 10.1080/07391102.2012.680026. Epub 2012 Jun 12.
3
Identification of inhibitor binding site in human sirtuin 2 using molecular docking and dynamics simulations.使用分子对接和动力学模拟鉴定人源 sirtuin 2 的抑制剂结合位点。
PLoS One. 2013;8(1):e51429. doi: 10.1371/journal.pone.0051429. Epub 2013 Jan 28.
4
Insight into the Mechanism of Intramolecular Inhibition of the Catalytic Activity of Sirtuin 2 (SIRT2).深入了解Sirtuin 2(SIRT2)催化活性的分子内抑制机制。
PLoS One. 2015 Sep 25;10(9):e0139095. doi: 10.1371/journal.pone.0139095. eCollection 2015.
5
Identification of Diketopiperazine-Containing 2-Anilinobenzamides as Potent Sirtuin 2 (SIRT2)-Selective Inhibitors Targeting the "Selectivity Pocket", Substrate-Binding Site, and NAD-Binding Site.鉴定含二酮哌嗪的 2-苯胺甲酰胺作为靶向“选择性口袋”、底物结合位点和 NAD 结合位点的强效 Sirtuin 2(SIRT2)选择性抑制剂。
J Med Chem. 2019 Jun 27;62(12):5844-5862. doi: 10.1021/acs.jmedchem.9b00255. Epub 2019 Jun 12.
6
Hit evaluation results in 5-benzyl-1,3,4-thiadiazole-2-carboxamide based SIRT2-selective inhibitor with improved affinity and selectivity.基于5-苄基-1,3,4-噻二唑-2-甲酰胺的SIRT2选择性抑制剂的命中评估结果显示其亲和力和选择性得到了提高。
Bioorg Chem. 2022 Jun;123:105746. doi: 10.1016/j.bioorg.2022.105746. Epub 2022 Mar 26.
7
Crystal structure analysis of human Sirt2 and its ADP-ribose complex.人源 Sirt2 及其 ADP-ribose 复合物的晶体结构分析。
J Struct Biol. 2013 May;182(2):136-43. doi: 10.1016/j.jsb.2013.02.012. Epub 2013 Feb 26.
8
Molecular modelling studies of sirtuin 2 inhibitors using three-dimensional structure-activity relationship analysis and molecular dynamics simulations.使用三维构效关系分析和分子动力学模拟对沉默调节蛋白2抑制剂进行分子建模研究。
Mol Biosyst. 2015 Mar;11(3):723-33. doi: 10.1039/c4mb00620h. Epub 2014 Dec 11.
9
Molecular docking and dynamics simulation, receptor-based hypothesis: application to identify novel sirtuin 2 inhibitors.分子对接和动力学模拟,基于受体假说:在鉴定新型 SIRT2 抑制剂中的应用。
Chem Biol Drug Des. 2012 Aug;80(2):315-27. doi: 10.1111/j.1747-0285.2012.01406.x. Epub 2012 Jun 21.
10
Screening approach by a combination of computational and in vitro experiments: identification of fluvastatin sodium as a potential SIRT2 inhibitor.通过计算和体外实验相结合的筛选方法:鉴定氟伐他汀钠为潜在的 SIRT2 抑制剂。
J Mol Model. 2024 May 27;30(6):188. doi: 10.1007/s00894-024-05988-z.

引用本文的文献

1
Integrative machine learning and molecular simulation approaches identify GSK3β inhibitors for neurodegenerative disease therapy.整合机器学习和分子模拟方法鉴定用于神经退行性疾病治疗的糖原合成酶激酶3β抑制剂。
Sci Rep. 2025 Jul 1;15(1):21632. doi: 10.1038/s41598-025-04129-7.
2
DFT and dynamic simulations of OleuoPectin structures as a potential anticoagulant agent.油果胶结构作为一种潜在抗凝血剂的密度泛函理论(DFT)及动态模拟
Sci Rep. 2025 Jun 20;15(1):20180. doi: 10.1038/s41598-025-06000-1.
3
Computational Evaluation of Fusarium nygamai Compounds as AcrD Efflux Pump Protein Inhibitors of Salmonella Typhimurium.

本文引用的文献

1
Identification of inhibitor binding site in human sirtuin 2 using molecular docking and dynamics simulations.使用分子对接和动力学模拟鉴定人源 sirtuin 2 的抑制剂结合位点。
PLoS One. 2013;8(1):e51429. doi: 10.1371/journal.pone.0051429. Epub 2013 Jan 28.
2
Molecular modeling study for conformational changes of Sirtuin 2 due to substrate and inhibitor binding.基于配体结合的 Sirtuin 2 构象变化的分子建模研究。
J Biomol Struct Dyn. 2012;30(3):235-54. doi: 10.1080/07391102.2012.680026. Epub 2012 Jun 12.
3
Molecular docking and dynamics simulation, receptor-based hypothesis: application to identify novel sirtuin 2 inhibitors.
对尼加马镰刀菌化合物作为鼠伤寒沙门氏菌AcrD外排泵蛋白抑制剂的计算评估
Mol Biotechnol. 2024 Dec 21. doi: 10.1007/s12033-024-01329-w.
4
Marine Compound-Carpatamide D as a Potential Inhibitor Against TOP2A and Its Mutant D1021Y in Colorectal Cancer: Insights from DFT, MEP and Molecular Dynamics Simulation.海洋化合物——卡帕他胺D作为结直肠癌中TOP2A及其突变体D1021Y的潜在抑制剂:来自密度泛函理论、分子静电势和分子动力学模拟的见解
Mol Biotechnol. 2024 Sep 12. doi: 10.1007/s12033-024-01265-9.
5
Structural and dynamic properties of eutectic mixtures based on menthol and fatty acids derived from coconut oil: a MD simulation study.基于椰子油衍生的薄荷醇和脂肪酸的共晶混合物的结构和动力学性质:MD 模拟研究。
Sci Rep. 2022 Mar 25;12(1):5153. doi: 10.1038/s41598-022-09185-x.
6
Structural Changes Due to Antagonist Binding in Ligand Binding Pocket of Androgen Receptor Elucidated Through Molecular Dynamics Simulations.通过分子动力学模拟阐明雄激素受体配体结合口袋中拮抗剂结合引起的结构变化。
Front Pharmacol. 2018 May 15;9:492. doi: 10.3389/fphar.2018.00492. eCollection 2018.
分子对接和动力学模拟,基于受体假说:在鉴定新型 SIRT2 抑制剂中的应用。
Chem Biol Drug Des. 2012 Aug;80(2):315-27. doi: 10.1111/j.1747-0285.2012.01406.x. Epub 2012 Jun 21.
4
Expression and molecular dynamics studies on effect of amino acid substitutions at Arg344 in human cathepsin A on the protein local conformation.人组织蛋白酶A中Arg344位点氨基酸取代对蛋白质局部构象影响的表达及分子动力学研究
Biochim Biophys Acta. 2009 Nov;1794(11):1693-9. doi: 10.1016/j.bbapap.2009.08.004. Epub 2009 Aug 11.
5
Investigating the ADP-ribosyltransferase activity of sirtuins with NAD analogues and 32P-NAD.利用烟酰胺腺嘌呤二核苷酸(NAD)类似物和32P-NAD研究沉默调节蛋白的ADP核糖基转移酶活性。
Biochemistry. 2009 Apr 7;48(13):2878-90. doi: 10.1021/bi802093g.
6
Paths of convergence: sirtuins in aging and neurodegeneration.汇聚路径:衰老与神经退行性变中的沉默调节蛋白
Neuron. 2008 Apr 10;58(1):10-4. doi: 10.1016/j.neuron.2008.03.015.
7
Therapeutic role of sirtuins in neurodegenerative disease.沉默调节蛋白在神经退行性疾病中的治疗作用。
Biochim Biophys Acta. 2008 Jun;1782(6):363-9. doi: 10.1016/j.bbadis.2008.02.010. Epub 2008 Mar 7.
8
The Sirtuin family: therapeutic targets to treat diseases of aging.沉默调节蛋白家族:治疗衰老相关疾病的靶点
Curr Opin Chem Biol. 2008 Feb;12(1):11-7. doi: 10.1016/j.cbpa.2008.01.019. Epub 2008 Mar 7.
9
Sirt2 interacts with 14-3-3 beta/gamma and down-regulates the activity of p53.沉默调节蛋白2(Sirt2)与14-3-3β/γ相互作用并下调p53的活性。
Biochem Biophys Res Commun. 2008 Apr 11;368(3):690-5. doi: 10.1016/j.bbrc.2008.01.114. Epub 2008 Feb 4.
10
Negative regulation of the deacetylase SIRT1 by DBC1.DBC1对去乙酰化酶SIRT1的负调控作用。
Nature. 2008 Jan 31;451(7178):587-90. doi: 10.1038/nature06515.